Eton Pharmaceutcials
ETON
50 hedge funds and large institutions have $28.8M invested in Eton Pharmaceutcials in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 5 closing their positions.
4,125% more call options, than puts
Call options by funds: $338K | Put options by funds: $8K
340% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
52% more funds holding
Funds holding: 33 → 50 (+17)
38% more capital invested
Capital invested by funds: $20.9M → $28.8M (+$7.91M)
3.46% more ownership
Funds ownership: 23.44% → 26.9% (+3.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
+$991K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$720K |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$637K |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$561K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$375K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Acuitas Investments
Seattle,
Washington
|
-$1.12M |
| 2 |
AIC
AWM Investment Company
New York
|
-$554K |
| 3 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$120K |
| 4 |
BlackRock
New York
|
-$50.4K |
| 5 |
B
Bailard
Foster City,
California
|
-$44.3K |
ETON Hedge Fund Activity: Q3 2023 in Review
50 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q3 2023, worth a combined $28.8M — up 38% from $20.9M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ETON positions and 5 closed out — a net gain of 17 holders — while 10 added to existing stakes and 5 trimmed.
The largest buyer was EAM Investors, opening a new position worth an estimated $991K. The largest seller was Acuitas Investments, cutting an estimated $1.12M.
- 50 institutional investors held Eton Pharmaceutcials (ETON) as of Q3 2023, up from 33 in Q2 2023.
- Funds reported $28.8M of Eton Pharmaceutcials stock for Q3 2023, up 38% quarter-over-quarter.
- 22 funds opened new Eton Pharmaceutcials positions in Q3 2023 and 5 closed out, a net change of +17 holders.
- The largest Eton Pharmaceutcials buyer in Q3 2023 was EAM Investors, an estimated $991K added.
- The largest Eton Pharmaceutcials seller in Q3 2023 was Acuitas Investments, an estimated $1.12M sold.
Based on aggregated 13F filings for Q3 2023.